Melo Caroline M, Maia Juliana L, Cavalcante Italo J, Lima Mary Anne, Vieira Gizelle Angela, Silveira Edilberto R, Rao Vietla S, Santos Flávia A
Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, CE, Brazil.
Planta Med. 2006 Jun;72(7):584-9. doi: 10.1055/s-2006-931564. Epub 2006 Apr 24.
The diterpene, 12-acetoxyhawtriwaic acid lactone (AHAL, tanabalin) isolated from the flower buds of Egletes viscosa Less. (Asteraceae) was evaluated on capsaicin-induced ear edema and hindpaw nociception in mice. AHAL (12.5, 25 and 50 mg/kg, P. O.) significantly attenuated the ear edema response to topically applied capsaicin (250 microg), in a dose-related manner. At similar doses, AHAL also suppressed the nocifensive paw-licking behavior induced by intraplantar injection of capsaicin (1.6 microg). These responses to capsaicin were also greatly inhibited by ruthenium red (3 mg/kg, S. C.), a non-competitive capsaicin receptor (TRPV1) antagonist. The anti-edema effect of AHAL (50 mg/kg) seems unrelated to either blockade of mast cell degranulation or to histamine and serotonin receptor antagonism since AHAL did not modify the paw edema response induced by intraplantar injections of compound 48/80, histamine or serotonin. However, the hindpaw edema induced by substance P and vascular permeability increase induced by intraperitoneal acetic acid were significantly suppressed by AHAL. The antinociceptive effect of AHAL (50 mg/kg) was unaffected by naloxone pretreatment but was significantly antagonized by theophylline and glibenclamide, the respective blockers of adenosine and K(ATP)-channels. AHAL (50 mg/kg, P. O.) did not impair the ambulation or motor coordination of mice in open-field and rota-rod tests. These data suggest that AHAL inhibits acute neurogenic inflammation possibly involving capsaicin-sensitive TRPV1-receptors, endogenous adenosine and ATP-sensitive potassium channels.
从菊科植物粘毛蟛蜞菊(Egletes viscosa Less.)的花蕾中分离得到的二萜类化合物12 - 乙酰氧基哈瓦三烯酸内酯(AHAL,塔纳巴林),在小鼠身上进行了辣椒素诱导的耳部水肿和后爪伤害感受实验评估。AHAL(12.5、25和50毫克/千克,口服)以剂量相关的方式显著减轻了局部应用辣椒素(250微克)引起的耳部水肿反应。在相似剂量下,AHAL还抑制了足底注射辣椒素(1.6微克)诱导的伤害性舔爪行为。对辣椒素的这些反应也被钌红(3毫克/千克,皮下注射)极大地抑制,钌红是一种非竞争性辣椒素受体(TRPV1)拮抗剂。AHAL(50毫克/千克)的抗水肿作用似乎与肥大细胞脱颗粒的阻断或组胺和5 - 羟色胺受体拮抗作用无关,因为AHAL并未改变足底注射化合物48/80、组胺或5 - 羟色胺诱导的爪部水肿反应。然而,P物质诱导的后爪水肿和腹腔注射醋酸诱导的血管通透性增加被AHAL显著抑制。AHAL(50毫克/千克)的抗伤害感受作用不受纳洛酮预处理的影响,但被茶碱和格列本脲分别显著拮抗,茶碱和格列本脲分别是腺苷和ATP敏感性钾通道的阻断剂。AHAL(50毫克/千克,口服)在旷场试验和转棒试验中并未损害小鼠的行走或运动协调性。这些数据表明,AHAL抑制急性神经源性炎症,可能涉及辣椒素敏感的TRPV1受体、内源性腺苷和ATP敏感性钾通道。